Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
- Resource Type
- Article
- Source
- The Lancet Gastroenterology & Hepatology; February 2021, Vol. 6 Issue: 2 p128-138, 11p
- Subject
- Language
- ISSN
- 24681253